Why the study?
Does multimodality treatment improve survival in patients with primary cardiac angiosarcoma?
Does multimodality treatment improve survival in patients with primary cardiac angiosarcoma?
Multimodality treatment including surgery, chemotherapy, radiotherapy, and targeted therapy may improve survival in patients with primary cardiac angiosarcoma.
Authors
No takes yet. Share an insight, caveat, or question.
Multimodality treatment may be considered in primary cardiac angiosarcoma; leaves open survival benefit in broader populations.
Wang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: